OLOL one of 51 sites selected for COVID-19 clinical trial 

Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.

Our Lady of the Lake Regional Medical Center today announced it’s selection as one of 51 U.S. sites to participate in a one-year study led by Vanderbilt University Medical Center of convalescent plasma as a treatment for COVID-19.  The study, Passive Immunity Trial for Our Nation (PassItOn), is funded through a $34 million grant from

This article is only available to paid Insiders

Become an Insider Now

Already an Insider? Sign in.

Comments (0)

From Our Partners

Daily Report Poll

ASK AI

Ask anything about Baton Rouge business